ArticleJournal of translational medicine2024

Exploring the role of PARP1 inhibition in enhancing antibody-drug conjugate therapy for acute leukemias: insights from DNA damage response pathway interactions.

Andrea Ghelli Luserna di Rorà et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.